CareDx, Inc. (CDNA)

NASDAQ: CDNA · IEX Real-Time Price · USD
22.36
-1.92 (-7.91%)
Aug 16, 2022 3:16 PM EDT - Market open
-7.91%
Market Cap 1.20B
Revenue (ttm) 314.86M
Net Income (ttm) -69.39M
Shares Out 53.46M
EPS (ttm) -0.95
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 379,272
Open 24.16
Previous Close 24.28
Day's Range 22.05 - 24.53
52-Week Range 19.35 - 81.45
Beta 0.88
Analysts Buy
Price Target 59.45 (+165.9%)
Earnings Date Aug 4, 2022

About CDNA

CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company also offers TruSight HLA, a next generation sequencing (NGS) based high resolution typing solu... [Read more...]

Industry Biotechnology
IPO Date Jul 17, 2014
CEO Peter Maag
Employees 633
Stock Exchange NASDAQ
Ticker Symbol CDNA
Full Company Profile

Financial Performance

In 2021, CareDx's revenue was $296.40 million, an increase of 54.22% compared to the previous year's $192.19 million. Losses were -$30.66 million, 63.8% more than in 2020.

Financial Statements

Analyst Forecast

According to 13 analysts, the average rating for CDNA stock is "Buy." The 12-month stock price forecast is 59.45, which is an increase of 165.88% from the latest price.

Price Target
$59.45
(165.88% upside)
Analyst Consensus: Buy
Stock Forecasts

News

CareDx and MOTTEP Co-Host Health Equity Summit

BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare ...

CareDx (CDNA) Reports Q2 Loss, Lags Revenue Estimates

CareDx (CDNA) delivered earnings and revenue surprises of -62.50% and 3.05%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

CareDx Reports Second Quarter 2022 Results

BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare ...

CareDx Unveils New Patient-Centered Medication Management Features on AlloCare Mobile Health App

BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare ...

CareDx Launches Personalized AlloHome Patient Monitoring Solution to Augment Pre- and Post-Transplant Care

BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare ...

CareDx to Report Second Quarter 2022 Financial Results

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value ...

CareDx Demonstrates Industry-Leading Commitment to Advancing Transplant Innovation as Distinguished Founder's Circle ...

BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare ...

CDNA SHAREHOLDER ALERT: Jakubowitz Law Reminds CareDx Shareholders of a Lead Plaintiff Deadline of July 22, 2022

NEW YORK , July 22, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of CareDx, Inc. (NASDAQ: CDNA). To receive updates ...

CDNA LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving CareDx, Inc

New York, New York--(Newsfile Corp. - July 21, 2022) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased CareDx, Inc. ("CareD...

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against CareDx, In...

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming July 22, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors w...

CDNA ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 22, 2022 in the Class Action Filed on Beha...

New York, New York--(Newsfile Corp. - July 21, 2022) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of CareDx, Inc. (NASDAQ: CDNA) alleging that th...

Bronstein, Gewirtz & Grossman, LLC Reminds CareDx, Inc. (CDNA) Shareholders of July 22, 2022 Class Action Deadline an...

New York, New York--(Newsfile Corp. - July 21, 2022) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against CareDx, Inc. ("CareDx" or the "Company") (...

CDNA FINAL DEADLINE: Hagens Berman, National Trial Attorneys, Encourages CareDx (CDNA) Investors with Significant Los...

San Francisco, California--(Newsfile Corp. - July 21, 2022) - Hagens Berman urges CareDx, Inc. (NASDAQ: CDNA) investors to with significant losses to submit your losses now. Class Period: Feb. 24, 2021 ...

Final Deadline: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Lead Plaintiff Deadline in Securities Fraud C...

RADNOR, Pa. , July 21, 2022 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against CareDx, Inc....

CDNA LAWSUIT ALERT: Levi & Korsinsky Notifies CareDx, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK , July 21, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in CareDx, Inc. ("CareDx" or the "Company") (NASDAQ: CDNA) of a class action securities lawsuit. CLASS DEFINITION: The l...

CDNA FINAL DEADLINE FRIDAY: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages CareDx, Inc. Investors with Losses to Sec...

NEW YORK , July 20, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of CareDx, Inc. (NASDAQ: CDNA) between February 24, 2021 and May 5, ...

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of CareDx, Inc. of a Class Action Lawsuit and a Lead Plai...

NEW YORK , July 20, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of CareDx, Inc.. Shareholders who purchased shares of CDNA during the class period listed are enco...

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages CareDx (CDNA) Investors with Significant Losses to Contact Firm's...

San Francisco, California--(Newsfile Corp. - July 19, 2022) - Hagens Berman urges CareDx, Inc. (NASDAQ: CDNA) investors to with significant losses to submit your losses now.Class Period: Feb. 24, 2021 -...

Deadline in 3 Days: Kessler Topaz Meltzer & Check, LLP Reminds CareDx, Inc. (CDNA) Investors of Filing Deadline in Cl...

Radnor, Pennsylvania--(Newsfile Corp. - July 19, 2022) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against...

CDNA Investors Have Opportunity to Lead CareDx, Inc. Securities Fraud Lawsuit

BENSALEM, Pa. , July 19, 2022 /PRNewswire/ -- Law Offices of Howard G.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CareDx, Inc. - CDNA

New York, New York--(Newsfile Corp. - July 19, 2022) - Pomerantz LLP is investigating claims on behalf of investors of CareDx, Inc. ("CareDx" or the "Company") (NASDAQ: CDNA). Such investors are advised...

CDNA ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 22, 2022 in the Class Action Filed on Beha...

NEW YORK , July 19, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of CareDx, Inc. (NASDAQ: CDNA) alleging that the Company viol...

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind CareDx Investors of a Lead Plaintiff Deadline of July 22, ...

NEW YORK , July 18, 2022 /PRNewswire/ -- Attention CareDx, Inc. ("CareDx") (NASDAQ: CDNA) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of in...

CDNA FINAL DEADLINE NOTICE: ROSEN, A RESPECTED AND LEADING FIRM, Encourages CareDx, Inc. Investors to Secure Counsel ...

New York, New York--(Newsfile Corp. - July 17, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of CareDx, Inc. (NASDAQ: CDNA) between February 24, 20...

Lead Plaintiff Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class ...

Radnor, Pennsylvania--(Newsfile Corp. - July 16, 2022) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against...